New Chairman at Drug Maker
471873
The Bristol-Myers Squibb Company, a drug maker, named its chief executive, James M. Cornelius, as board chairman, succeeding James D. Robinson III.
168037
Pfizer Inc.  abruptly replaced  Chief Executive Hank McKinnell on Friday, selecting its top  lawyer, Jeffrey Kindler, to run the world's largest drugmaker.
626436
Pfizer Inc.  on Monday boosted its quarterly dividend 21 percent after the surprise failure of its most important experimental drug that caused a sell-off in its shares, and gave its chief executive additional duties as chairman.
435276
The troubled pharmaceutical company begins to show signs of life.
562473
The drugmaker announces another great quarter of growth.
318366
Retiring Rep. Billy Tauzin, who once led the House committee that oversees drug makers and helped write the bill to expand Medicare prescription coverage, will become the head
296490
The small pharmaceutical firm signs another big deal.
17097
The generic drug maker&#39;s deal to buy King Pharmaceuticals was supposed to mark its arrival in the brand-name drug business. Instead, it put the spotlight on a new CEO&#39;s strategy that billionaire investor Carl Icahn doesn&#39;t like.
48329
Biopharmaceutical company Human Genome Sciences Inc. said Monday that it named H. Thomas Watkins as chief executive officer and a director to succeed William A. Haseltine, founder and former chairman and CEO, who retired from the company effective Oct.
639887
Learn a lesson or two from the drugmaker's dance with the FDA.
420620
An interview with Panacos Pharmaceuticals CEO Alan Dunton.
174409
The company's lead drug will enter phase 1 trials, bringing potential good fortune to investors.
573459
A key study of its lead drug proceeds faster than expected.
494627
An interview with development-stage drugmaker Pharmacopeia.
15160
The Swiss pharmaceutical company Roche Holding said its chief executive would step down next March as the company separates that job from the chairmanâs position. Franz B. Humer, who has been chief since 1998, will remain chairman of the board. Next July, he also will become chairman of the beverage company Diageo. He will be succeeded by Severin Schwan, 40, who had been the head of Rocheâs diagnostics unit since January. The company also posted a 24 percent increase in first-half net profit, to 4.92 billion Swiss francs ($4.1 billion) from 3.97 billion francs in the period a year earlier. Roche benefited from its flu treatment Tamiflu as governments stockpile the drug in case of an influenza pandemic.
693961
WASHINGTON Nov 5, 2004 - Buffeted by criticism, the Food and Drug Administration said Friday that it would appoint a director of drug safety and take other steps to improve the safety of medications.
438501
Here's what a newly approved drug looks like.